Board of Management

Genome Research Limited (GRL), the Institute's governing body, delegates authority to a Board of Management. The main objectives of the Board of Management are to ensure delivery of strategic aims and objectives, to provide leadership across the whole Institute and to ensure high standards of scientific, corporate and charity governance.

The members of the Board of Management are:

Campbell, Peter

Campbell, Peter
Peter Campbell
Head of Cancer, Ageing and Somatic Mutation, and Senior Group Leader